PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+15.77%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$13.5B
AUM Growth
+$1.89B
(+16%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
31.74%
Holding
335
New
58
Increased
110
Reduced
92
Closed
41
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$159M |
| 2 |
Johnson & Johnson
JNJ
|
$156M |
| 3 |
Chegg
CHGG
|
$85M |
| 4 |
Medtronic
MDT
|
$74.6M |
| 5 |
Humana
HUM
|
$71.3M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$135M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$123M |
| 3 |
Ciena
CIEN
|
$99.1M |
| 4 |
Advanced Micro Devices
AMD
|
$87.5M |
| 5 |
Zoom
ZM
|
$74.1M |
Sector Composition
| 1 | Technology | 35.5% |
| 2 | Healthcare | 19.85% |
| 3 | Financials | 14.53% |
| 4 | Communication Services | 13.92% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Bank of N.T. Butterfield & Son
NTB
$1.88B
| $614K | ﹤0.01% |
27,550
-620
| -2% | -$13.8K |
|
252
Pennant Group
PNTG
$828M
| $605K | ﹤0.01% |
+15,700
| New | +$605K |
|
253
Globus Medical
GMED
$8.22B
| $586K | ﹤0.01% |
11,825
-134
| -1% | -$6.64K |
|
254
United Therapeutics
UTHR
$17.5B
| $562K | ﹤0.01% |
5,565
+2,990
| +116% | +$302K |
|
|
MGLN
255
DELISTED
Magellan Health Services, Inc.
MGLN
| $552K | ﹤0.01% |
7,281
+1,416
| +24% | +$107K |
|
|
CHNG
256
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $540K | ﹤0.01% |
37,248
+18,382
| +97% | +$266K |
|
257
Tactile Systems Technology
TCMD
$299M
| $495K | ﹤0.01% |
13,527
-582,115
| -98% | -$21.3M |
|
258
iRhythm Technologies
IRTC
$5.88B
| $480K | ﹤0.01% |
2,017
+35
| +2% | +$8.33K |
|
259
Haemonetics
HAE
$2.63B
| $464K | ﹤0.01% |
5,322
| – | – |
|
|
AMED
260
DELISTED
Amedisys
AMED
| $448K | ﹤0.01% |
1,893
-205,267
| -99% | -$48.6M |
|
|
ARNA
261
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $435K | ﹤0.01% |
5,816
| – | – |
|
262
Owens & Minor
OMI
$419M
| $408K | ﹤0.01% |
16,250
-10,000
| -38% | -$251K |
|
263
ICU Medical
ICUI
$3.18B
| $406K | ﹤0.01% |
2,223
| – | – |
|
264
uniQure
QURE
$970M
| $401K | ﹤0.01% |
10,893
-222,405
| -95% | -$8.19M |
|
|
RCM
265
DELISTED
R1 RCM Inc. Common Stock
RCM
| $366K | ﹤0.01% |
21,343
-18,285
| -46% | -$314K |
|
266
Veracyte
VCYT
$2.52B
| $345K | ﹤0.01% |
10,611
| – | – |
|
|
NVRO
267
DELISTED
NEVRO CORP.
NVRO
| $340K | ﹤0.01% |
2,444
| – | – |
|
268
QuidelOrtho
QDEL
$1.95B
| $339K | ﹤0.01% |
1,547
-1,999
| -56% | -$438K |
|
|
LHCG
269
DELISTED
LHC Group LLC
LHCG
| $313K | ﹤0.01% |
1,473
| – | – |
|
|
SPNE
270
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $285K | ﹤0.01% |
19,901
| – | – |
|
|
FENG
271
Phoenix New Media
FENG
$30.9M
| $245K | ﹤0.01% |
33,146
+12,309
| +59% | +$91K |
|
272
CONMED
CNMD
$1.73B
| $234K | ﹤0.01% |
+2,974
| New | +$234K |
|
273
Bruker
BRKR
$4.62B
| $224K | ﹤0.01% |
+5,632
| New | +$224K |
|
274
Vericel Corp
VCEL
$1.7B
| $206K | ﹤0.01% |
+11,108
| New | +$206K |
|
|
GNMK
275
DELISTED
GenMark Diagnostics, Inc
GNMK
| $158K | ﹤0.01% |
+11,100
| New | +$158K |
|